(Q43640243)

English

Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study

scientific article published on 6 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

3

object named as

Hisao Ogawa

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Kunihiko Matsui

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Shokei Kim-Mitsuyama

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Tomio Jinnouchi

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hideaki Jinnouchi

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kikuo Arakawa

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

OlmeSartan Calcium Antagonists Randomized (OSCAR) Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

6 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

526-532

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

https://scigraph.springernature.com/pub.10.1038/hr.2014.23

0 references

Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Treatment of mild to moderate hypertension by gender perspective: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and c

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Statistics in medicine--reporting of subgroup analyses in clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

The challenge of subgroup analyses--reporting without distorting

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

21 January 2018

Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension in women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.23

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2014.23

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43640243&oldid=2102044744"